Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales
- 1 October 2004
- Vol. 22 (31-32) , 4203-4214
- https://doi.org/10.1016/j.vaccine.2004.05.003
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Vaccination of day-care center attendees reduces carriage of Streptococcus pneumoniae among their younger siblingsThe Pediatric Infectious Disease Journal, 2003
- Pneumococcal conjugate vaccines: proceedings from an Interactive Symposium at the 41st Interscience Conference on Antimicrobial Agents and ChemotherapyVaccine, 2003
- Impact of the pneumococcal conjugate vaccine on otitis mediaThe Pediatric Infectious Disease Journal, 2003
- Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumoniaThe Pediatric Infectious Disease Journal, 2002
- Invasive pneumococcal disease in England and Wales: what is the true burden and what is the potential for prevention using 7 valent pneumococcal conjugate vaccine?Archives of Disease in Childhood, 2002
- Reduction of Nasopharyngeal Carriage ofStreptococcus pneumoniaeafter Administration of a 9‐Valent Pneumococcal Conjugate Vaccine to Toddlers Attending Day Care CentersThe Journal of Infectious Diseases, 2002
- Meningitis in infancy in England and Wales: follow up at age 5 yearsBMJ, 2001
- Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelinesThorax, 2001
- Efficacy of a Pneumococcal Conjugate Vaccine against Acute Otitis MediaNew England Journal of Medicine, 2001
- Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in childrenThe Pediatric Infectious Disease Journal, 2000